Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death

Molecular Neurobiology

Volumn 24, Issue 1-3, 2001, Pages 107-129

  Sattler, Rita ^a   Tymianski, Michael ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Calcium; Glutamate receptor; Neurotoxicity; Postsynaptic density

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL DEATH; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; NERVE CELL; NEUROTOXICITY; POSTSYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

EID: 0035693680     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:24:1-3:107     Document Type: Article

References (198)

1. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology
2. Cloned glutamate receptors
3. The toxic effect of sodium L-glutamate on the inner layers of the retina
4. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate
5. Glutamate neurotoxicity and Huntington's chorea
6. Synaptic activity mediates death of hypoxic neurons
7. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain
8. Glutamate neurotoxicity and diseases of the nervous system
9. Cytosolic calcium concentrations and cell death in vitro
10. Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury
11. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
12. Molecular mechanisms of calcium-dependent excitotoxicity
13. Zn(2+): A novel ionic mediator of neural injury brain in disease
14. 2+ permeable AMPA or kainate receptors: Possible key factors in selective neurodegeneration
15. Mediation of neuronal apoptosis by enhancement of outward potassium current
16. Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro
17. Glutamate neurotoxicity in cortical cell culture
18. Ionic dependence of glutamate neurotoxicity
19. Pharmacology of AMPA antagonists and their role in neuroprotection
20. Calcium transport and buffering in neurons
21. Calcium and cellular death
22. Does neuroprotection improve stroke outcome?
23. Calcium signaling in neurons: Molecular mechanisms and cellular consequences
24. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons
25. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity
26. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein
27. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways
28. 2+ channels
29. Reflections on Ca(2+)-channel diversity, 1988-1994
30. Structure of ionotropic glutomate receptors
31. Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing
32. RNA editing of AMPA receptor subunit GluR-B: A base-paired intronexon structure determines position and efficiency
33. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
34. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels
35. Organization and regulation of proteins at synapses
36. PDZ domains in synapse assembly and signalling
37. Post-synaptic organization and regulation of excitatory synapses
38. Enlightening the postsynaptic density
39. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands
40. GRASP-l: A neuronal Ras-GEF associated with the AMPA receptor/GRIP complex
41. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins
42. The contributions of GluR2 to allosteric modulation of AMPA receptors
43. LTP mechanisms: From silence to four-lane traffic
44. Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis
45. Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins
46. Kainate receptors
47. 2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6
48. 2+ permeability in both TM1 and TM2 of high affinity kainate receptor channels: Diversity by RNA editing
49. Kainate receptor subunits expressed in single cultured hippocampal neurons: Molecular and functional variants by RNA editing
50. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95
51. SAP90 binds and clusters kainate receptors causing incomplete desensitization
52. Identification of a site in glutamate receptor subunits that controls calcium permeability
53. Cellular and subcellular distribution of glutamate receptors
54. Combinations of AMPA receptor subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins
55. Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells
56. 2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated toxicity
57. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells
58. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS
59. Calcium directly permeates kainate/alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons
60. Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression
61. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability
62. Enhanced LTP in mice deficient in the AMPA receptor GluR2
63. The influence of glutamate receptor 2 expression on excitotoxicity in GluR2 null mutant mice
64. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B
65. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function
66. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice
67. The AMPAR subunit GluR2: Still front and center-stage
68. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats
69. 2+ influx in hippocampal CA1 neurons of gerbil
70. Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons
71. Unchanged balance between levels of mRNA encoding AMPA glutamate receptor subtypes following global cerebral ischemia in the rat
72. Relative concentrations and seizure-induced changes in mRNAs encoding three AMPA receptor subunits in hippocampus and cortex
73. Changes in gene expression of AMPA-selective glutamate receptor subunits induced by status epilepticus in rat brain
74. Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death
75. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background
76. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
77. Interaction of the N-ethyl-maleimide-sensitive factor with AMPA receptors
78. The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs
79. NSF binding to GluR2 regulates synaptic transmission
80. Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism
81. Assembly of proteins to postsynaptic densities after transient cerebral ischemia
82. Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease
83. Rapid, activation-induced redistribution of ionotropic glutamate receptor in cultured hippocampal neurons
84. Functional kainate-selective glutamate receptors in cultured hippocampal neurons
85. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate
86. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons
87. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2, 3-benzo-diazepines
88. The synaptic activation of kainate receptors
89. Kainate receptors: Subunits, synaptic localization and function
90. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus
91. Kainate receptors are involved in synaptic plasticity
92. Fate of the hippocampal mossy fiber projection after destruction of its postsynaptic targets with intraventricular kainic acid
93. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
94. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice
95. Q/R editing of the rat GluR5 and GluR6 kainate receptors in vivo and in vitro: Evidence for independent developmental, pathological and cellular regulation
96. Human GluR6 kainate receptor (GRIK2): Molecular cloning, expression, polymorphism, and chromosomal assignment
97. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease
98. Presynaptic kainate receptors in the monkey striatum
99. Evidence for the GluR6 gene associated with younger onset age of Huntington's disease
100. RNA editing of brain glutamate receptor channels: Mechanism and physiology
101. Generation and analysis of GluR5(Q636R) kainate receptor mutant mice
102. The role of RNA editing of kainate receptors in synaptic plasticity and seizures
103. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor
104. Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro
105. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95
106. Alternatively spliced isoforms of the NMDARI receptor subunit
107. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits
108. Evidence for a tetrameric structure of recombinant NMDA receptors
109. 2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor
110. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines
111. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor
112. Coupling of permeation and gating in an NMDA-channel pore mutant
113. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit
114. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
115. Molecular diversity of the NMDA receptor channel
116. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death
117. Functional NMDA receptors are transiently active and support the survival of Purkinje cells in culture
118. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice
119. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit
120. Single-channel conductances of NMDA receptors expressed from cloned cDNAs: Comparison with native receptors
121. Characterization of excitatory amino acid neurotoxicity in N-methyl-D-aspartate receptor-deficient mouse cortical neuronal cells
122. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions
123. Dysfunctions in mice by NMDA receptor point mutations NR1(N598Q) and NR1(N598R)
124. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
125. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA
126. Age-related changes in the relative abundance of NMDAR1 mRNA spliced variants in the rat brain
127. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat
128. The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain
129. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants
130. Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit
131. Protein kinase C modulation of recombinant NMDA receptor currents: Roles for the C-terminal CI exon and calcium ions
132. Inactivation of NMDA receptors by direct interaction of calmodulin with the NRI subunit
133. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors
134. Axonal injury alters alternative splicing of the retinal NRI receptor: The preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival
135. Role of NMDA receptor functional domains in excitatory cell death
136. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor
137. High actin concentrations in brain dendritic spines and postsynaptic densities
138. Isoform specificity in the relationship of actin to dendritic spines
139. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: Differential attachment of NMDA versus AMPA receptors
140. Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors
141. Molecular mechanisms of glutamate receptor clustering at excitatory synapses
142. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin
143. In vivo toxicity of prion protein in murine scrapie: Ultrastructural and immunogold studies
144. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy
145. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
146. Calcium-dependent inactivation of synaptic NMDA receptors in hippocampal neurons
147. Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons
148. A direct comparison of the single-channel properties of synaptic and extrasynaptic NMDA receptors
149. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity
150. Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1
151. Splice variant-specific interaction of the NMDA receptor subunit NRI with neuronal intermediate filaments
152. Regulated subcellular distribution of the NRI subunit of the NMDA receptor
153. Development of intracellular calcium responses to depolarization and to kainate and N-methyl-D-aspartate in cultured mouse hippocampal neurons
154. Vulnerability of CA1 neurons to glutamate is developmentally regulated
155. 2+ in cerebral cortex neurons is transient in immature cells but permanent in mature cells
156. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
157. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
158. NMDA receptor heterogeneity during postnatal development of the rat brain: Differential expression of the NR2A, NR2B, and NR2C subunit protiens
159. Activity-dependent regulation of N-methyl-D-aspartate receptor subunit expression in rat cerebellar granule cells
160. Presynaptic exocytosis regulates NR2A mRNA expression in cultured neocortical neurones
161. Regulation of kinetic and pharmacological properties of synaptic NMDA receptors depends on presynaptic exocytosis in rat hippocampal neurones
162. Selective up-regulation of an NMDA receptor subunit mRNA in cultured cerebellar granule cells by K(+)-induced depolarization and NMDA treatment
163. Functional evaluation of glutamate receptor subtypes in cultured cerebellar neurones and astrocytes
164. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture
165. Functional change of NMDA receptors related to enhancement of susceptibility to neurotoxicity in the developing pontine nucleus
166. Developmental expression of NMDA receptor subunits and the emergence of glutamate neurotoxicity in primary cultures of murine cerebral cortical neurons
167. Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels
168. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death
169. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule
170. Mice with genetically modified NMDA and AMPA receptors
171. Attenuation of focal ischemic brain injury in mice deficient in the epsilon 1 (NR2A) subunit of NMDA receptor
172. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon 1 subunit
173. Attenuation of focal cerebral infarct in mice lacking NMDA receptor subunit NR2C
174. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo
175. Role of the carboxy-terminal region of the GluR epsilon2 subunit in synaptic localization of the NMDA receptor channel
176. C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors
177. Modeling buffered Ca2+ diffusion near the membrane: Implications for secretion in neuroendocrine cells
178. Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways
179. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
180. Excitatory synapses. Glutamate receptors put in their place
181. PDZ domains: Targeting signalling molecules to sub-membranous sites
182. Nitric oxide signaling in the nervous system
183. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains
184. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences
185. Cyclic GMP and cell death in rat cerebellar slices
186. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
187. Enhanced long-term potentiation and imparied learning in mice with mutant postsynaptic density-95 protein
188. Modulation of the channel activity of the epsilon2/zetal -subtype N-methyl-D-aspartate receptor by PSD-95
189. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade
190. SynGAP: A synaptic RasGAP that associates with the PSD-95/SAP90 protein family
191. A synaptic RasGTPase activating protein (p135 SynGAP) inhibited by CaM kinase II
192. Citron, a Rho-target, interacts with PSD-95/SAP-90 at glutamatergic synapses in the thalamus
193. Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus
194. PSD-95 promotes Fyn-mediated typrosine phsophorylation of the N-methyl-D-aspartate receptor subunit NR2A
195. Modification of postsynaptic densities after transient cerebral ischemia: A quantitative and three-dimensional ultrastructural study
196. Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia
197. Altered association of protein tyrosine kinases with postsynaptic densities after transient cerebral ischemia in the rat brain